Amgen Inc.
NASDAQ: AMGN0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Select
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- CEO
- Robert A. Bradway
- Employees
- 28,000
- Headquarters
- Thousand Oaks, United States
- IPO year
- 1983
- Market cap
- $195.0B
- Website
- https://www.amgen.com
Loading AMGN…
Loading profile data…Frequently asked questions about AMGN
What does Amgen Inc. (AMGN) do?
Amgen Inc., established in 1980 and headquartered in Thousand Oaks, California, is a global biotechnology leader focused on discovering, developing, manufacturing, and delivering groundbreaking human medicines. The company's scientific endeavors span several critical therapeutic categories, including inflammatory conditions, oncology and hematol...
Where does AMGN trade?
Amgen Inc. (AMGN) trades on the NASDAQ Global Select.
What sector is AMGN in?
Amgen Inc. (AMGN) operates in the Healthcare sector, specifically in the Drug Manufacturers - General industry.
Who is the CEO of Amgen Inc.?
Robert A. Bradway is the chief executive officer of Amgen Inc. (AMGN).
Where is Amgen Inc. headquartered?
Amgen Inc. is headquartered in United States.
When did AMGN go public?
Amgen Inc. (AMGN) completed its initial public offering in 1983.